Shenyang Xingqi Pharmaceutical Co.,Ltd.

300573

CNE100002DV1

Pharmaceuticals

End-of-day quote Shenzhen S.E. Other stock markets 2025-01-21			5-day change	1st Jan Change
71.52 ^CNY	+0.13%		-1.68%	+2.49%

Oct. 28	Shenyang Xingqi Pharmaceutical Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2024	CI
Sep. 22	Shenyang Xingqi Pharmaceutical Co.,Ltd.(XSEC:300573) added to FTSE All-World Index	CI

Shenyang Xingqi Pharmaceutical Co.,Ltd. Approves Interim Cash Dividend for the 2024

September 18, 2024 at 03:38 pm EDT

Shenyang Xingqi Pharmaceutical Co.,Ltd. at its EGM held on September 13, 2024 approved interim cash dividend of CNY 5.00000000 per 10 shares (tax included) for the 2024.

Latest news about Shenyang Xingqi Pharmaceutical Co.,Ltd.

Shenyang Xingqi Pharmaceutical Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2024	24-10-28	CI
Shenyang Xingqi Pharmaceutical Co.,Ltd.(XSEC:300573) added to FTSE All-World Index	24-09-22	CI
Shenyang Xingqi Pharmaceutical Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2024	24-08-28	CI
Xingqi Pharmaceutical Gets Nod to Trial Eye Drops; Shares Up 4%	24-07-25	MT
Xingqi Pharmaceutical Gets Nod to Register Bromfenac Sodium Eye Drops; Shares Down 3%	24-07-24	MT
Space Peptides announced that it has received funding from Humanwell Healthcare Co.,Ltd., Shenyang Xingqi Pharmaceutical Co.,Ltd., Xiamen Furuier Pharmaceutical Co., Ltd., Purple Knight Capital and other investors	24-05-21	CI
Shenyang Xingqi Pharmaceutical's Q1 Profit Jumps 80%	24-04-26	MT
Shenyang Xingqi Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	24-04-25	CI
Shenyang Xingqi Pharmaceutical Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	24-04-18	CI
Xingqi Pharma Gets Nod to Market Atropine Sulfate Eye Drop; Shares Up 3%	24-03-13	MT
Shenyang Xingqi Pharmaceutical Co.,Ltd. Approves Board Elections	24-01-08	CI
Shenyang Xingqi Pharmaceutical Co.,Ltd.(SZSE:300573) added to Shenzhen Stock Exchange Component Index	23-12-12	CI
Shenyang Xingqi Pharmaceutical Co.,Ltd.(SZSE:300573) added to Shenzhen Stock Exchange Component A Share Index	23-12-12	CI
Xingqi Pharmaceutical's Diquafosol Sodium Eye Drops Bags China's Centralized Drug Bid	23-11-08	MT
Shenyang Xingqi Pharmaceutical Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-23	CI
Shenyang Xingqi Pharmaceutical Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-28	CI
Xingqi Pharmaceutical Enrolls First Subject for Phase 4 Trial of Eye Drops	23-08-17	MT
Shenyang Xingqi Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-26	CI
Shenyang Xingqi Pharmaceutical Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-19	CI
Shenyang Xingqi Pharmaceutical Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-26	CI
Shenyang Xingqi Pharmaceutical Co.,Ltd Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-28	CI
Shenyang Xingqi Pharmaceutical Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2022	22-04-26	CI
Shenyang Xingqi Pharmaceutical Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2021	22-04-19	CI
Shenyang Xingqi Pharmaceutical Raises $91.5 Million From Private Share Sale	22-01-17	MT
Shenyang Xingqi Pharmaceutical Co.,Ltd announced that it has received CNY 599.669492 million in funding from a group of investors	22-01-13	CI

Chart Shenyang Xingqi Pharmaceutical Co.,Ltd.

Duration

Period

Chart Shenyang Xingqi Pharmaceutical Co.,Ltd.

300573: Dynamic Chart

SHENYANG XINGQI PHARMACEUTICAL CO., LTD. is a China-based company principally engaged in the research, development, manufacture and distribution of ophthalmic drugs. The Companyâs main products are ophthalmic prescription drugs, including corneal repairing drugs, anti-bacteria drugs, artificial tears, anti-inflammation drugs, anti-allergic drugs, as well as anti-hyperemia & fatigue relief drugs and others. The Company mainly distributes its products within domestic market.

Employees

1,995

Sector

Pharmaceuticals

Calendar

2025-04-17 - Q4 2024 Earnings Release (Projected)

More about the company